Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile.

Journal of lipid research - 1 Nov 2005

van der Vleuten Gerly M, van Tits Lambertus J H, den Heijer Martin, Lemmers Heidi, Stalenhoef Anton F H, de Graaf Jacqueline

Abstract excerpt

Familial combined hyperlipidemia (FCH) is characterized by increased levels of total cholesterol, triglycerides, and/or apolipoprotein B. Other features of FCH are obesity and insulin resistance. Adiponectin is a secretory product of the adipose tissue. Low levels of adiponectin are associated with insulin resistance and accelerated atherosclerosis. The aim of this study was to determine whether decreased...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin
Share to Adipose Tissue

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Atherosclerosis

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Hyperlipidemia, Familial Combined

Share to Hyperlipidemias

Share to Waist-Hip Ratio

Source

Identifiers

PMID: 16106049
DOI: 10.1194/jlr.M500212-JLR200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile.PMID 16106049Read ↗

Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD.Semantic proximity Read ↗

Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment.Semantic proximity Read ↗

Role of insulin resistance in familial combined hyperlipidemia.Semantic proximity Read ↗

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategiesSemantic proximity Read ↗

Genetics of familial combined hyperlipidemia.Semantic proximity Read ↗

Metabolic disorders and inflammation are associated with familial combined hyperlipemia.Semantic proximity Read ↗

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.Semantic proximity Read ↗

Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.Semantic proximity Read ↗

Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.Semantic proximity Read ↗

Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.Semantic proximity Read ↗

Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.Semantic proximity Read ↗

Up-Regulation of the Complement System in Subcutaneous Adipocytes from Nonobese, Hypertriglyceridemic Subjects Is Associated with Adipocyte Insulin ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.